Abstract
Background The Dietary Guidelines for Americans (DGA) recommends consuming >1.75g/wk of long-chain omega-3 fatty acids to reduce the risk of cardiovascular disease (CVD) through triglyceride reduction, however individual responses to treatment vary.
Objective We sought to determine if a DGA-conforming diet (DGAD) can increase the omega-3 index (OM3I), a diet-sensitive biomarker of omega-3 fatty acid status, into a health promoting range and reduce fasting triglycerides in 8 weeks. We further explored determinants of the basal OM3I and its response to treatment.
Design This is a secondary analysis of a randomized, double-blind 8wk dietary intervention of overweight/obese women fed an 8d rotating DGAD (n =22) or typical American diet (TAD; n =20) registered at www.clinicaltrials.gov as NCT02298725. The DGAD and TAD provided individuals with 16 ± 2 g/wk and 1.2 ± 0.12 g/wk of eisocapentaenoic acid (EPA) + docosahexaenoic acid (DHA), respectively. Habitual diet and body composition were determined at baseline. OM3I, fasting triglycerides, glucose and insulin were measured at 0, 2 and 8wk.
Results Baseline OM3I (5.8 ± 1.3; n =42) was positively correlated to the dietary (EPA+DHA):dietary fat ratio (p =0.006), negatively correlated to the android fat mass (p =0.0007) and was not different between diet groups. At 8wk, while the TAD-group average OM3I was unchanged (5.8 ± 0.76), the DGAD-group OM3I increased (7.33 ± 1.36; p <0.001). In the DGAD-group 9 of 22 (i.e. 41%) participants achieving an OM3I >8%. Subgroup analyses of the DGAD-group revealed that body fat content and distribution influenced the baseline-dependent response to treatment. Fasting triglyceride and OM3I changes did not correlate.
Conclusions An 8wk TAD stabilized the OM3I in a healthy range, while a DGAD increased the OM3I into a health-promoting range, but did not reduce fasting triglycerides. Fat distribution and basal omega-3 status are primary factors influencing omega-3 efficacy in overweight/obese women.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02298725
Funding Statement
This study was supported by the National Dairy Council, Campbell Soup Co., and USDA-ARS Projects 2032-51530-022-00D, 2032-51530-025-00D and 6026-51000-010-05S. The USDA is an equal opportunity provider and employer. The National Dairy Council and Campbell Soup Company did not participate in the final design, implementation, analysis, or interpretation of the data from this study. Campbell Soup provided some bulk foods and associated nutrient information.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures were approved by the University of California, Davis (UC Davis), Institutional Review Board.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are included as supplement in PDF form. All data will be available upon publication. Early requests for a more accessible data will be considered by the senior authors.
Abbreviations
- ALA
- alpha-linolenic acid
- FFQs
- Block Food Frequency questionnaires
- CVD
- cardiovascular disease
- Delta-OM3I(Wk0-8)
- 8wk omega 3 index change from baseline
- DGA
- Dietary Guidelines for Americans
- GC-MS
- gas chromatography-mass spectrometry
- DEXA
- dual-energy x-ray absorptiometry
- FAME
- fatty acid methyl esters
- OM3I
- omega-3 index
- OM3I(Wk0)
- baseline omega 3 index
- RBC
- red blood cell
- SFAT
- dietary saturated fat
- TAD
- typical American diet
- TFAT
- total dietary fat
- TG
- triglycerides
